Research|GOOG: The Market Sees Brain Drain; We See a Long-Overdue Organizational Consolidation
Our read on the Google AI leadership changes is a bit different from the market’s initial reaction.
On the surface, this is clearly a significant exodus of senior talent. Jeff Dean, Sanjay Ghemawat, Quoc Le, Oriol Vinyals, and several others among the most senior and influential technical leaders in Google’s history are leaving. Demis Hassabis is also moving from CEO of Google DeepMind to Chair and Alphabet Chief Scientist, with Koray Kavukcuoglu taking on more of the day-to-day operating responsibility. Understandably, the market sees this as a major brain drain.
But we think the actual impact may be considerably smaller than the headlines suggest - and over the medium term, the changes could even prove constructive.
One important reason is that, despite their enormous historical contributions, many of the senior people now leaving had already become increasingly peripheral to the core Gemini / frontier-LLM effort over the past year or two. They remain world-class researchers, but there is an important distinction between the people who were historically most important to Google AI and the people actually driving frontier-model execution today.
In fact, we think Google’s bigger problem may have started after the success of Gemini 3.
Gemini 3 established itself as arguably the leading multimodal model, while Google already had one of the strongest proprietary compute infrastructures in the industry. At the same time, DeepMind’s work, including AlphaFold, had achieved Nobel-level scientific recognition. It would have been easy for the organization to conclude that the frontier-model race had largely been caught up - or even temporarily won - and that the highest-value use of its most exceptional talent was to go after the next generation of major scientific breakthroughs.
That helps explain why Demis and several other senior researchers increasingly shifted their attention away from the more engineering-heavy work of frontier-model scaling and toward AI for Science, drug discovery,y and other longer-horizon, potentially Nobel-level problems. For researchers of that caliber, the attraction is completely understandable.